Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT07504913
Recruiting Observational

Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41

NCT07504913 · tracked via the Priya Life Science Spain tracker
Sponsor
Parc de Salut Mar
Phase
Observational
Started
2025-05-03
Last updated
2026-04-01

Condition(s) studied

Stomach NeoplasmsValidation Study

Investigational drug(s) / intervention(s)

Development Questionnaire and Validation Questionnaire

Development Questionnaire and Validation Questionnaire: The intervention consists of administering the questionnaires at the different phases of the study.

Study summary

The main objective of this study is the translation, linguistic adaptation into Spanish, and validation of the Korean quality of life questionnaire KOQUSS-40. This tool will allow us to objectively measure the quality of life of patients in clinical trials.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients operated on for gastric cancer with curative intent from 1 month postoperatively up to the last 5 years * Adult patients over 18 years old * No recurrence of the disease * Patients who have given their informed consent to participate in the Spanish EURECCA Registry of Esophagogastric Cancer and have signed the specific consent for the SPQUSS-4 study Exclusion Criteria: * First 30 days after surgery and/or patients with postoperative complications requiring more than 30 days of hospitalization. * Patients who do not give their consent to participate in the study will be excluded. * Patients with a history of other neoplasms. * Patients with disseminated gastric cancer or candidates for palliative surgery, as well as those patients who do not give their consent to participate.

Primary outcome measure(s)

  • Spanish validation of KOQUSS-40 questionnaire — At baseline and after 30 days.
    The main objective of this study is the translation and linguistic adaptation into Spanish, as well as the validation, of the Korean quality-of-life questionnaire KOQUSS-40, originally developed in the Korean setting (SPQUSS, SPanish QUality of life in Stomach cancer patients Study group). This tool will allow us to objectively measure patients' quality of life in clinical trials.

Trial sites (6)

FacilityCityRegionStatus
Hospital Universitario Germans Trias y Pujol Badalona Barcelona Recruiting
Hospital Universitario Vall d'Hebron Barcelona Barcelona Recruiting
Hospital Universitario de Bellvitge L'Hospitalet de Llobregat Barcelona Active Not Recruiting
Hospital Universitario Puerto Real Puerto Real Cadiz Recruiting
Hospital Universitario San Pedro Logroño La Rioja Recruiting
Hospital Universitario Arnau de Vilanova Lleida Lleida Recruiting

More Parc de Salut Mar trials in Spain

Shock Wave Therapy for Lower Limb Lymphedema Recruiting
Adaptation Plan for Culturally Competent Care (PAACI) in the Acute Psychiatric Unit. Active, not recruiting
Effectiveness of Treatments for Massive Rotator Cuff Tears: Mixed Methodology. Active, not recruiting
Use of Intraoperative Radiotherapy in Breast Cancer Enrolling by invitation
Zn Supplementation in HIV Immunological Non Responders Recruiting

Other trials for the same condition

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors Recruiting
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC) Active, not recruiting
Spanish Series of Patients Treated With the Radionuclide Lutetium177 Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07504913 on ClinicalTrials.gov ↗ ← All trials in Spain